Date:02/01/2009 URL: http://www.thehindu.com/2009/01/02/stories/2009010255731500.htm

Business - Briefly

Aurobindo Pharma gets FDA nod

HYDERABAD: Aurobindo Pharma announced here on Wednesday that two of its tentatively approved ANDAs (Abbreviated New Drug Applications), Stavudine capsules 15mg, 20mg, 30mg and 40mg and Stavudine for oral solution 1mg/ml received the final approval from the U.S. Food & Drug Administration (USFDA). Aurobindo now had 63 final and 24 tentative ANDA approvals from USFDA. — Special Correspondent